FDA is reviewing certain health-software functions today. The useful lesson is not anti-tech: good tools organize information, but people still need to understand what action the information supports.
FDA is reviewing certain health-software functions today. The useful lesson is not anti-tech: good tools organize information, but people still need to understand what action the information supports.